MedTrace Logo

Diagnosis of Osteogenesis Imperfecta in Children

NCT03169192 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-05-30

No results posted yet for this study

Summary

The study will be conducted at Assiut university children hospital and it will include patients with history of repeated fractures due to mild or irrelevant trauma.

Diagnosis will be established by biochemical tests, bone survey to exclude secondary causes followed by Dual Energy absorbiometry scan to detect bone density of selected cases then confirm our diagnosis by detection of gene mutations of Osteogenesis imperfecta during one and half year duration with starting zoledronic acid therapy during this duration.

Conditions

  • Bone Disease, Metabolic

Interventions

DRUG

Zoledronic Acid

intravenous injections once every 3 months

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2019-01-01
Completion
2019-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03169192 on ClinicalTrials.gov